Matthew E. Walsh is a doctoral student in the department of Environmental Health and Engineering (health security track) at Johns Hopkins Bloomberg School of Public Health and a member of the 2018 cohort of the Emerging Leaders in Biosecurity Initiative (ELBI). His dissertation work focuses on the impacts of artificial intelligence and biotechnology on the biological threat landscape. He currently serves as a graduate student representative to the Association for Politics and the Life Sciences. Previously, he was Associate Staff in the Biological and Chemical Technologies group at MIT Lincoln Laboratory (MIT LL), a Department of Defense research and development laboratory. He established a technical program at MIT LL to develop and apply machine learning methods to engineering biology with a focus on rapid medical countermeasures and antibody-based therapeutics. Mr. Walsh also has supported work in biosensor development, threat attribution, warfighter health, and biological data assurance. Prior to MIT LL, he worked at MassBiologics of the University of Massachusetts Medical School, developing assays for the characterization of therapeutic monoclonal antibody production. Mr. Walsh received a BA in chemistry from Skidmore College.